Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2009);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;11.689;Q1;193;19;64;2367;1438;64;23.06;124.58;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;9.362;Q1;210;15;73;5918;1152;63;16.56;394.53;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741776;6.955;Q1;289;198;479;7612;5329;364;11.97;38.44;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;22321;Trends in Pharmacological Sciences;journal;01656147;5.016;Q1;201;84;261;5718;2421;245;9.19;68.07;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
5;4700152457;Nano Today;journal;17480132;4.977;Q1;119;54;86;3241;545;51;12.06;60.02;Netherlands;Elsevier BV;2006-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
6;19409;Advanced Drug Delivery Reviews;journal;0169409X;4.23;Q1;278;141;345;15219;3864;297;12.87;107.94;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
7;21195;Pharmacology and Therapeutics;journal;01637258;4.101;Q1;180;97;311;19032;3082;308;9.39;196.21;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
8;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.995;Q1;194;300;784;28684;4784;777;5.98;95.61;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
9;12611;Drug Resistance Updates;journal;13687646, 15322084;3.991;Q1;100;16;48;1836;492;48;12.17;114.75;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
10;18017;Neuropsychopharmacology;journal;0893133X;3.59;Q1;204;269;868;16631;5330;803;6.61;61.83;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
11;20681;Current Opinion in Pharmacology;journal;14714892;3.52;Q1;120;117;316;6206;2074;279;7.28;53.04;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
12;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;3.408;Q1;58;0;13;0;91;13;11;0;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
13;12455;Molecular Therapy;journal;15250024, 15250016;3.36;Q1;158;273;748;10816;4192;656;6.45;39.62;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;19907;Medicinal Research Reviews;journal;01986325, 10981128;3.062;Q1;119;20;83;3958;747;81;9.05;197.9;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;26371;Natural Product Reports;journal;02650568, 14604752;2.925;Q1;157;75;185;10568;1293;177;7.23;140.91;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
16;23010;Journal of Controlled Release;journal;01683659;2.922;Q1;237;301;859;10896;5306;829;6.21;36.2;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
17;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.916;Q1;166;154;496;5947;2268;450;5.14;38.62;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;18148;Pain;journal;03043959;2.702;Q1;238;349;966;12952;5130;765;6.13;37.11;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
19;20626;Clinical Pharmacology and Therapeutics;journal;00099236;2.51;Q1;173;245;649;5568;3600;533;6.22;22.73;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
20;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.433;Q1;186;266;1128;11429;5095;1099;4.51;42.97;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
21;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.424;Q1;232;830;1903;25406;9250;1775;4.95;30.61;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
22;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.375;Q1;127;130;396;5854;1760;372;4.78;45.03;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
23;29311;Current Cancer Drug Targets;journal;15680096;2.329;Q1;85;59;182;7558;948;170;5.47;128.1;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
24;5100155080;Neurotherapeutics;journal;19337213;2.326;Q1;100;75;178;6608;932;163;5.91;88.11;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;20104;CNS Drug Reviews;journal;1080563X, 15273458;2.211;Q1;52;0;30;0;176;29;5.24;0;United States;Neva Press, Inc.;1996-2007;"Neuropsychology and Physiological Psychology (Q1); Pharmacology (Q1)"
26;24749;Addiction Biology;journal;13556215, 13691600;2.185;Q1;70;46;110;2702;496;104;4.53;58.74;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
27;21782;Psychopharmacology;journal;00333158;2.178;Q1;181;385;973;22863;3970;921;4.01;59.38;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
28;4400151524;Particle and Fibre Toxicology;journal;17438977;2.16;Q1;83;29;47;1486;279;45;5;51.24;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
29;20084;British Journal of Pharmacology;journal;00071188;2.126;Q1;190;555;1291;25018;6111;1225;4.99;45.08;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
30;21000196010;Topics in antiviral medicine;journal;21615853;2.076;Q1;37;15;53;311;171;52;4.59;20.73;United States;International Antiviral Society;2011-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
31;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;2.075;Q1;98;36;104;4927;603;96;4.17;136.86;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
32;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.037;Q1;161;268;808;11347;3506;797;4.2;42.34;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
33;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.034;Q1;240;847;2394;35494;11816;2348;4.8;41.91;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
34;26380;Drug and Alcohol Dependence;journal;03768716;2.025;Q1;151;268;733;12443;2844;702;3.89;46.43;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
35;25218;Toxicological Sciences;journal;10960929, 10966080;2.018;Q1;164;274;858;13150;4219;803;5;47.99;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
36;23916;Environmental Pollution;journal;02697491, 18736424;2.002;Q1;194;458;1324;20286;4936;1300;3.43;44.29;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
37;22072;Current Gene Therapy;journal;15665232;1.983;Q1;65;44;128;5188;655;124;5.53;117.91;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Genetics (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
38;21196;Drug Discovery Today;journal;13596446;1.979;Q1;157;155;446;8118;2584;417;6.18;52.37;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
39;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1.902;Q1;172;581;1329;13580;5313;1034;5;23.37;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
40;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.897;Q1;93;137;259;6467;952;232;4.15;47.2;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
41;20063;Biochemical Pharmacology;journal;00062952;1.896;Q1;181;323;1021;18154;4760;944;4.55;56.2;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
42;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;1.875;Q1;45;0;45;0;221;41;5.81;0;United States;Neva Press, Inc.;1988-2007;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
43;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.851;Q1;209;448;1619;15951;6731;1591;4.06;35.6;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
44;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.85;Q1;81;53;206;2214;557;186;2.84;41.77;United Kingdom;Nature Publishing Group;2006-ongoing;"Epidemiology (Q1); Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
45;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.841;Q1;110;191;284;8689;1545;268;5.66;45.49;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
46;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.825;Q1;102;128;435;9394;1852;429;4.52;73.39;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
47;20435;Neuropharmacology;journal;00283908;1.807;Q1;150;252;730;15008;2662;723;3.89;59.56;United Kingdom;Elsevier Ltd.;1962-ongoing;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
48;20664;Current Drug Targets;journal;13894501;1.775;Q1;92;128;406;12307;1550;358;4.03;96.15;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
49;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.772;Q1;78;28;152;2090;566;134;4.07;74.64;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
50;23488;Current Medicinal Chemistry;journal;09298673;1.758;Q1;158;275;715;43053;3647;705;4.98;156.56;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
51;4000148203;Handbook of Experimental Pharmacology;book series;01712004;1.728;Q1;81;157;326;19347;1168;307;3.86;123.23;Germany;Springer Verlag;2005-ongoing;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
52;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.728;Q1;70;15;59;1793;269;53;4;119.53;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
53;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.722;Q1;75;68;206;4462;914;186;5.14;65.62;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
54;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.676;Q1;78;44;125;1914;605;122;4.51;43.5;United Kingdom;Nature Publishing Group;2001-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1); Genetics (Q2)"
55;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;1.637;Q1;110;224;223;9047;847;200;4.24;40.39;United States;Public Library of Science;2007-ongoing;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
56;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.626;Q1;143;236;717;12666;2349;689;3.36;53.67;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
57;21790;Antiviral Therapy;journal;13596535;1.619;Q1;78;135;370;4995;1313;353;3.88;37;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
58;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.612;Q1;106;48;114;1519;580;111;5.58;31.65;Netherlands;Elsevier BV;2005-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
59;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.608;Q1;64;47;121;3276;495;115;3.04;69.7;Germany;Springer Verlag;2006-ongoing;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2); Neuroscience (miscellaneous) (Q2)"
60;20682;Current Pharmaceutical Design;journal;13816128;1.605;Q1;140;346;961;40283;3894;858;4.71;116.42;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
61;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.585;Q1;191;264;769;12132;3274;735;4.3;45.95;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
62;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;1.583;Q1;89;89;239;3555;851;234;3.42;39.94;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
63;26512;Tetrahedron;journal;00404020;1.545;Q1;209;1201;3747;62430;11828;3681;3.34;51.98;United Kingdom;Elsevier Ltd.;1957-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
64;12331;Current Topics in Medicinal Chemistry;journal;15680266;1.542;Q1;104;145;432;12874;1550;369;4.08;88.79;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
65;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1.533;Q1;138;193;655;8349;2307;647;3.4;43.26;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
66;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.506;Q1;144;228;664;10511;2463;629;3.92;46.1;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
67;20624;Clinical Pharmacokinetics;journal;03125963;1.494;Q1;150;60;197;4237;1024;187;5.26;70.62;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
68;16088;Journal of Nanobiotechnology;journal;14773155;1.49;Q1;57;9;33;326;126;31;5.06;36.22;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
69;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;1.487;Q1;69;12;40;2263;163;39;3.96;188.58;United States;Begell House;1984-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
70;5400152706;Nanotoxicology;journal;17435390, 17435404;1.478;Q1;72;27;51;1134;261;50;5.22;42;United Kingdom;Informa Healthcare;2007-ongoing;"Biomedical Engineering (Q1); Toxicology (Q1); Nanoscience and Nanotechnology (Q2)"
71;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.472;Q1;161;303;864;9731;3464;848;3.92;32.12;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
72;21354;Expert Opinion on Therapeutic Targets;journal;14728222;1.469;Q1;78;106;321;10517;1054;299;3.75;99.22;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
73;23053;Journal of Natural Products;journal;01633864, 15206025;1.466;Q1;124;426;1138;11677;3538;1108;3.31;27.41;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
74;144771;Clinical Trials;journal;17407753, 17407745;1.453;Q1;55;69;176;1812;309;152;1.9;26.26;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
75;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.45;Q1;89;26;113;4882;529;108;4.89;187.77;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
76;4000148019;AAPS Journal;journal;15507416;1.441;Q1;96;84;192;4702;879;183;3.84;55.98;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q1)
77;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.424;Q1;82;90;164;8976;650;150;4.18;99.73;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
78;24763;Addictive Behaviors;journal;03064603;1.407;Q1;114;174;681;6564;1781;679;2.5;37.72;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
79;22454;International Journal of Pharmaceutics;journal;03785173;1.399;Q1;190;476;1645;15489;5494;1627;3.18;32.54;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
80;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.393;Q1;76;51;229;3062;633;226;2.77;60.04;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
81;21237;Drug Safety;journal;01145916;1.384;Q1;115;97;282;4999;1121;236;4.61;51.54;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
82;25075;Ecotoxicology;journal;09639292, 15733017;1.38;Q1;81;137;211;5375;656;209;3.62;39.23;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
83;23109;Journal of Psychopharmacology;journal;02698811;1.378;Q1;106;130;389;5108;1182;322;3.33;39.29;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
84;14144;Experimental and Clinical Psychopharmacology;journal;10641297;1.367;Q1;82;49;157;2355;422;157;2.75;48.06;United States;American Psychological Association;1993-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
85;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.339;Q1;116;87;310;3730;834;302;2.07;42.87;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
86;21169;Pharmacological Research;journal;10436618, 10961186;1.333;Q1;118;103;368;6685;1324;356;4.26;64.9;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q1)
87;15576;European Neuropsychopharmacology;journal;0924977X;1.309;Q1;100;108;307;4905;1002;300;3.34;45.42;Netherlands;Elsevier BV;1990-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2); Neurology (Q2)"
88;21197;Pharmacology Biochemistry and Behavior;journal;00913057;1.309;Q1;126;266;687;14052;1932;682;2.93;52.83;United States;Elsevier Inc.;1973-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
89;25109;Inhalation Toxicology;journal;08958378, 10917691;1.302;Q1;77;62;339;2543;841;315;2.97;41.02;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
90;26514;Tetrahedron Letters;journal;00404039;1.296;Q1;159;1814;5471;60470;14623;5405;2.76;33.34;United Kingdom;Elsevier Ltd.;1959-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
91;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1.291;Q1;114;259;831;11487;2209;699;3.18;44.35;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
92;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.29;Q1;153;300;902;15363;3117;881;3.55;51.21;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
93;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.283;Q1;33;32;93;745;122;80;1.62;23.28;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
94;28792;Cancer Biology and Therapy;journal;15384047;1.28;Q1;101;373;1052;13268;2184;792;2.45;35.57;United States;Landes Bioscience;2002-ongoing;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
95;20783;Expert Review of Vaccines;journal;14760584;1.278;Q1;75;154;308;11198;1058;271;4.28;72.71;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q1); Pharmacology (Q1); Immunology (Q2); Molecular Medicine (Q2)"
96;19617;Antiviral Research;journal;01663542;1.277;Q1;108;126;353;5816;1406;348;3.93;46.16;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q2)"
97;20679;Current Opinion in Investigational Drugs;journal;14724472;1.276;Q1;71;130;352;9121;1154;319;3.75;70.16;United Kingdom;Current Drugs Ltd.;1994, 2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
98;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.26;Q1;87;113;355;3924;1126;350;3.12;34.73;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
99;23079;Journal of Pharmaceutical Sciences;journal;00223549;1.253;Q1;159;396;875;17370;2765;816;3.28;43.86;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
100;21351;Expert Opinion on Investigational Drugs;journal;13543784;1.251;Q1;94;152;467;10565;1697;425;4.42;69.51;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
101;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.249;Q1;60;78;204;5421;641;182;3.82;69.5;United Kingdom;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
102;15581;Current Pharmaceutical Biotechnology;journal;13892010;1.249;Q1;73;58;169;4645;532;149;3.83;80.09;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
103;23014;Journal of Drug Targeting;journal;10292330, 1061186X;1.236;Q1;80;69;239;2324;694;219;3.08;33.68;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
104;22983;Journal of Clinical Pharmacology;journal;00912700;1.235;Q1;106;121;425;3362;1487;399;3.93;27.79;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
105;20663;Current Drug Metabolism;journal;13892002;1.223;Q1;97;88;246;12374;1124;235;4.28;140.61;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
106;110172;Progress in Drug Research;book series;0071786X;1.223;Q1;38;0;33;0;96;30;3.2;0;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
107;4400151608;ChemMedChem;journal;18607187, 18607179;1.205;Q1;92;204;497;8731;1508;485;3.16;42.8;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
108;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;1.2;Q1;114;362;1463;9224;4005;1447;2.72;25.48;Netherlands;Elsevier BV;1983-ongoing;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1)"
109;19427;Advances in Pharmacology;book series;10543589;1.198;Q1;68;13;62;1947;181;57;3.76;149.77;United States;Elsevier Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
110;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.194;Q1;63;58;184;2266;409;148;2.66;39.07;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
111;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.187;Q1;131;218;700;6385;2071;532;3.8;29.29;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
112;18073;NeuroToxicology;journal;0161813X;1.187;Q1;102;154;402;7278;1251;375;2.97;47.26;Netherlands;Elsevier BV;1979-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
113;21165;PharmacoEconomics;journal;11707690;1.186;Q1;91;91;272;3631;638;215;3.25;39.9;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
114;21331;European Journal of Pharmaceutical Sciences;journal;09280987;1.18;Q1;119;195;359;7409;1302;349;2.61;37.99;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
115;4600151527;Infectious Disorders - Drug Targets;journal;18715265;1.17;Q1;49;48;85;4711;250;76;2.83;98.15;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
116;18966;Mutagenesis;journal;02678357, 14643804;1.169;Q1;82;63;147;2947;585;140;3.91;46.78;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
117;25219;Toxicology;journal;0300483X;1.159;Q1;143;255;877;10789;2901;851;3.29;42.31;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q1)
118;18075;Neurotoxicology and Teratology;journal;08920362;1.15;Q1;89;46;175;2591;543;170;3.27;56.33;Netherlands;Elsevier BV;1987-ongoing;"Toxicology (Q1); Developmental Neuroscience (Q2); Cellular and Molecular Neuroscience (Q3)"
119;22477;Investigational New Drugs;journal;01676997, 15730646;1.146;Q1;80;76;205;2312;563;202;2.99;30.42;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
120;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;1.142;Q1;83;97;293;4006;757;285;2.7;41.3;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
121;13250;Expert Opinion on Biological Therapy;journal;14712598;1.137;Q1;75;140;390;11189;1245;384;3.39;79.92;United Kingdom;Taylor & Francis;2001-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
122;84948;Expert Opinion on Drug Delivery;journal;17425247;1.136;Q1;88;82;192;7693;587;177;3.08;93.82;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
123;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.135;Q1;98;175;467;7097;966;462;1.77;40.55;Germany;Springer Verlag;1973-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
124;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.13;Q1;142;894;2365;33745;7162;2348;2.87;37.75;United Kingdom;Elsevier Ltd.;1993-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
125;20051;BioDrugs;journal;11738804;1.124;Q1;60;30;113;2406;367;106;4.24;80.2;United Kingdom;Adis International Ltd.;1997-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
126;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1.123;Q1;133;1472;3712;37729;10082;3668;2.77;25.63;United Kingdom;Elsevier Ltd.;1991-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
127;25240;Toxicology Letters;journal;03784274;1.09;Q1;129;284;625;11374;2171;599;3.49;40.05;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
128;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;1.088;Q1;100;297;669;9067;1783;650;2.74;30.53;Germany;Springer Verlag;1978-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
129;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1.085;Q1;89;70;173;3008;548;167;3.02;42.97;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
130;23015;Journal of Ethnopharmacology;journal;03788741;1.085;Q1;170;455;1163;16407;3606;1141;2.79;36.06;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
131;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;1.081;Q2;74;173;536;5849;1358;524;2.23;33.81;Netherlands;Elsevier BV;1996-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
132;29712;Clinical Therapeutics;journal;01492918;1.079;Q2;123;286;744;9352;2564;669;3.49;32.7;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
133;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;1.077;Q2;54;32;97;869;212;94;2.13;27.16;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q2)
134;25125;Journal of Analytical Toxicology;journal;01464760;1.07;Q1;69;101;306;2131;637;284;2.37;21.1;United States;Perston Publications, Inc.;1977-ongoing;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2)"
135;17595;Journal of Biomolecular Screening;journal;10870571;1.067;Q1;69;117;288;2914;725;283;2.47;24.91;United States;Sage Science Press;1996-ongoing;"Biotechnology (Q1); Drug Discovery (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
136;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;1.063;Q2;91;122;437;5505;1162;425;2.92;45.12;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
137;21167;Pharmacogenomics;journal;14622416;1.051;Q2;83;186;449;8961;1460;394;3.65;48.18;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Genetics (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
138;18071;Neurotoxicity Research;journal;10298428;1.05;Q2;65;62;148;3802;433;148;2.55;61.32;United States;Springer New York LLC;2001-ongoing;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
139;22378;Vascular Pharmacology;journal;15371891;1.049;Q2;86;81;253;3287;667;246;2.19;40.58;Netherlands;Elsevier BV;2002-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2); Physiology (Q2)"
140;21333;European Journal of Pharmacology;journal;00142999;1.048;Q2;167;601;2253;26208;6404;2236;2.72;43.61;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q2)
141;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.047;Q2;67;58;162;2772;381;159;2.52;47.79;Netherlands;Elsevier BV;1996, 1998-ongoing;"Biochemistry (Q2); Pharmacology (Q2); Physiology (Q2); Cell Biology (Q3)"
142;23155;Current Vascular Pharmacology;journal;15701611;1.046;Q2;54;49;99;5957;295;92;3.12;121.57;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
143;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.042;Q1;61;34;106;1415;258;104;2.57;41.62;United States;Mary Ann Liebert Inc.;2011-ongoing;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
144;16948;Chirality;journal;1520636X, 08990042;1.04;Q1;73;136;341;5770;772;327;2.58;42.43;United States;John Wiley & Sons Inc.;1989-ongoing;"Drug Discovery (Q1); Analytical Chemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
145;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;1.039;Q1;55;80;311;2486;592;214;2.91;31.08;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
146;14990;Current Neuropharmacology;journal;1570159X;1.038;Q2;58;19;81;2246;178;78;1.86;118.21;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2); Neurology (clinical) (Q2); Pharmacology (Q2)"
147;20473;Life Sciences;journal;00243205;1.029;Q1;150;241;1428;9535;4045;1422;2.75;39.56;Netherlands;Elsevier BV;1962-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
148;7700153108;International journal of nanomedicine;journal;11782013, 11769114;1.018;Q2;100;28;157;727;476;150;2.96;25.96;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Medicine (miscellaneous) (Q1); Bioengineering (Q2); Biomaterials (Q2); Biophysics (Q2); Drug Discovery (Q2); Nanoscience and Nanotechnology (Q2); Organic Chemistry (Q2)"
149;24652;Chemico-Biological Interactions;journal;00092797;1.001;Q2;108;295;425;12906;1458;415;2.77;43.75;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
150;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;0.99;Q2;99;159;373;8013;1021;371;2.7;50.4;Netherlands;Elsevier BV;2000-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Physiology (Q2); Toxicology (Q2); Cell Biology (Q3)"
151;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.987;Q2;30;26;82;1496;220;77;2.98;57.54;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
152;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.984;Q2;54;32;106;1270;215;91;2.47;39.69;United States;John Wiley & Sons Inc.;2003-ongoing;"Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
153;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;0.984;Q2;79;130;369;12518;1137;365;2.99;96.29;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
154;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;0.981;Q1;58;52;178;1667;487;168;2.49;32.06;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
155;4000150314;Chemical Biology and Drug Design;journal;17470277;0.964;-;71;142;327;5049;815;312;2.43;35.56;United Kingdom;Blackwell;2006-ongoing;"Biochemistry (Q2); Molecular Medicine (Q2)"
156;17464;European Journal of Medicinal Chemistry;journal;02235234;0.964;Q2;135;626;622;21928;2098;614;3.37;35.03;Netherlands;Elsevier BV;1974-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
157;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.958;Q2;89;98;322;4025;796;301;2.33;41.07;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q2)"
158;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.954;Q2;36;25;70;2577;215;70;2.58;103.08;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Drug Discovery (Q2); Oncology (Q2)"
159;4700152848;PPAR Research;journal;16874757, 16874765;0.952;Q2;40;35;149;2512;311;138;2.24;71.77;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Pharmacology (medical) (Q1); Drug Discovery (Q2)"
160;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.951;Q2;72;125;260;11138;894;252;3.39;89.1;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
161;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.945;Q2;90;0;323;0;862;315;2.54;0;United Kingdom;Taylor & Francis;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
162;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.941;Q2;88;133;408;4194;1048;403;2.48;31.53;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
163;24785;Alcohol;journal;07418329;0.94;Q2;74;62;186;3414;415;179;2.55;55.06;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
164;24028;Reproductive Toxicology;journal;08906238;0.937;Q2;99;118;374;5617;1169;346;3.67;47.6;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q2)
165;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;0.927;Q2;39;37;34;1698;88;28;3.14;45.89;United States;Wiley-Blackwell;2008-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
166;19034;Microbial Drug Resistance;journal;10766294;0.915;Q2;62;37;135;732;267;134;1.86;19.78;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Immunology (Q3)"
167;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.911;Q2;42;38;88;3022;241;84;2.76;79.53;United Arab Emirates;Bentham Science Publishers;2006-2015;"Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
168;14805;Steroids;journal;0039128X;0.907;Q2;95;152;417;5317;1119;414;3.04;34.98;Netherlands;Elsevier BV;1963-ongoing;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
169;24604;Archives of Toxicology;journal;14320738, 03405761;0.892;Q2;96;120;279;5156;819;257;3.46;42.97;Germany;Springer Verlag;1972-ongoing;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
170;17067;Phytomedicine;journal;09447113;0.89;Q1;105;156;406;4412;1106;394;2.64;28.28;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
171;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.884;Q2;78;87;296;3457;541;287;1.89;39.74;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
172;22575;Cardiovascular Toxicology;journal;15307905;0.884;Q2;47;27;76;1104;217;76;2.78;40.89;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
173;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.873;Q2;95;199;603;8256;1397;578;2.16;41.49;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
174;14822;Xenobiotica;journal;00498254, 13665928;0.865;Q2;75;81;235;2949;632;233;2.73;36.41;United Kingdom;Taylor & Francis;1971-ongoing;"Medicine (miscellaneous) (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2)"
175;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.863;Q2;43;45;109;5224;268;109;2.67;116.09;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
176;19984;Assay and Drug Development Technologies;journal;1540658X;0.859;Q2;52;41;286;1170;386;162;2.65;28.54;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3)"
177;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.858;Q2;87;93;383;3618;919;353;2.48;38.9;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
178;20602;Clinical Neuropharmacology;journal;03625664;0.856;Q2;74;98;177;2350;449;161;2.75;23.98;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
179;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.851;Q2;68;44;129;1576;349;116;2.54;35.82;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
180;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;0.848;Q2;44;38;97;1324;202;93;2.16;34.84;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
181;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.845;Q2;99;144;503;4403;1305;445;2.9;30.58;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
182;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;0.841;Q1;61;33;141;940;256;123;1.67;28.48;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
183;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.839;Q2;78;115;308;3677;798;301;2.45;31.97;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
184;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;0.839;Q2;59;36;28;2081;59;26;2.27;57.81;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Physiology (medical) (Q2); Psychiatry and Mental Health (Q2)"
185;25096;Food and Chemical Toxicology;journal;02786915;0.833;Q2;149;399;1199;16218;2956;1174;2.3;40.65;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
186;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0.833;Q2;80;114;503;4538;833;490;1.61;39.81;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
187;19900192900;Molecular Informatics;journal;18681751, 18681743;0.83;Q2;60;123;281;4191;736;267;2.91;34.07;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
188;25214;Toxicologic Pathology;journal;15331601, 01926233;0.83;Q2;96;75;315;3069;609;286;1.99;40.92;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
189;22318;Toxicological Reviews;journal;11762551;0.823;Q2;42;0;16;0;82;16;0;0;United Kingdom;Adis International Ltd.;2003-2006;"Pharmacology (Q2); Toxicology (Q2)"
190;23942;Biomedical Chromatography;journal;10990801, 02693879;0.822;Q2;58;165;544;4197;949;537;1.73;25.44;United States;John Wiley & Sons Inc.;1986-ongoing;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
191;130025;Current Drug Delivery;journal;15672018;0.808;Q1;54;64;115;2687;303;114;2.59;41.98;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q1)
192;5800173383;Current Clinical Pharmacology;journal;15748847;0.796;Q1;33;29;64;1790;186;64;2.78;61.72;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
193;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.792;Q2;50;25;108;993;186;105;1.52;39.72;United States;Elsevier Inc.;1971-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
194;22432;International Immunopharmacology;journal;15675769;0.791;Q2;98;234;658;9330;1525;633;2.29;39.87;Netherlands;Elsevier BV;2001-ongoing;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
195;25224;Toxicology in Vitro;journal;08872333;0.791;Q2;96;189;628;7659;1580;615;2.24;40.52;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
196;21744;Planta Medica;journal;14390221, 00320943;0.777;Q1;103;227;688;5649;1360;663;1.89;24.89;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
197;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.771;Q2;64;57;190;1887;438;182;2.36;33.11;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
198;130063;Pharmacological Reports;journal;17341140, 22995684;0.77;Q2;71;133;349;6082;751;342;2.11;45.73;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
199;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0.758;Q2;80;136;407;4864;957;397;2.29;35.76;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
200;22319;Toxicon;journal;00410101;0.756;Q2;116;251;729;10966;1608;706;2.17;43.69;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q2)
201;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.754;Q2;60;180;174;5300;377;170;2.22;29.44;United States;Taylor and Francis;2008-ongoing;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
202;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.754;Q2;34;21;123;1189;286;117;2.38;56.62;United Kingdom;Adis International Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
203;4400151410;Human Vaccines;journal;15548600, 15548619;0.751;Q1;49;130;150;4661;321;123;2.5;35.85;United States;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q3)"
204;23039;Journal of Liposome Research;journal;08982104, 15322394;0.751;Q1;44;22;81;822;172;80;1.79;37.36;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q1)
205;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.749;Q2;77;116;353;5866;633;346;1.46;50.57;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
206;21455;Progress in Medicinal Chemistry;book series;00796468;0.746;Q2;33;15;18;961;28;15;2.5;64.07;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Pharmacology (Q2); Molecular Medicine (Q3)"
207;20634;Journal of Texture Studies;journal;00224901;0.744;Q1;48;43;120;1177;193;114;1.5;27.37;United States;Wiley-Blackwell;1969-ongoing;"Food Science (Q1); Pharmaceutical Science (Q1)"
208;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.743;Q2;29;19;70;2426;175;70;2.62;127.68;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
209;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0.741;Q2;53;73;195;2093;348;190;1.81;28.67;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
210;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.739;Q2;90;119;330;4621;656;297;2;38.83;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
211;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.737;Q1;104;352;1295;10716;2619;1284;1.93;30.44;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
212;145164;Human Genomics;journal;14739542, 14797364;0.735;Q2;49;39;43;585;60;32;1.5;15;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q2); Genetics (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
213;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.724;Q2;37;31;82;2650;179;80;2.13;85.48;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
214;16533;Phytochemical Analysis;journal;09580344, 10991565;0.723;Q2;63;68;196;1568;321;194;1.69;23.06;United States;John Wiley & Sons Inc.;1990-ongoing;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
215;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.719;Q2;84;263;1041;6395;1817;1037;1.75;24.32;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
216;21865;Fundamental and Clinical Pharmacology;journal;07673981;0.707;Q2;64;91;215;3924;448;203;2.16;43.12;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
217;23412;Journal of AOAC International;journal;10603271;0.696;Q2;79;210;560;4572;852;554;1.24;21.77;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q1); Food Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Pharmacology (Q2)"
218;16573;Phytotherapy Research;journal;10991573, 0951418X;0.696;Q2;112;287;721;8238;1557;711;1.96;28.7;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q2)
219;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.692;Q2;53;42;129;1482;245;122;2.13;35.29;United States;John Wiley & Sons Inc.;1998-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
220;25093;Environmental Toxicology;journal;15227278, 15204081;0.69;Q2;69;62;226;2694;415;223;1.76;43.45;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
221;20570;Chemotherapy;journal;00093157, 14219794;0.681;Q2;49;51;177;1598;302;170;1.97;31.33;Switzerland;S. Karger AG;1963-ongoing;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
222;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.676;Q2;79;222;726;6489;1098;722;1.53;29.23;United States;Wiley-Blackwell;1918-ongoing;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3)"
223;19443;American Journal of Health-System Pharmacy;journal;10792082;0.672;Q2;87;375;1241;5911;1464;808;1.88;15.76;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
224;15840;Journal of Antibiotics;journal;00218820;0.671;Q2;73;131;302;2803;424;282;1.49;21.4;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
225;4700152612;Current Nanoscience;journal;15734137;0.664;Q1;37;32;125;1722;223;122;1.49;53.81;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q3)"
226;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.662;Q1;70;82;187;2502;328;186;1.56;30.51;United Kingdom;Taylor & Francis;1984-ongoing;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2)"
227;22410;Inflammation Research;journal;1420908X, 10233830;0.66;Q2;82;148;346;4680;550;340;1.54;31.62;Switzerland;Birkhauser Verlag;1995-ongoing;"Pharmacology (Q2); Immunology (Q3)"
228;25898;Journal of Peptide Science;journal;10752617, 10991387;0.659;Q2;60;108;347;4244;527;334;1.64;39.3;United States;John Wiley & Sons Inc.;1995-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
229;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.648;Q2;54;212;223;3413;356;216;1.42;16.1;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
230;19374;AAPS PharmSciTech;journal;15221059, 15309932;0.646;Q1;79;130;371;3850;579;363;1.17;29.62;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
231;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.642;Q2;43;39;220;677;209;192;1.08;17.36;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q3)"
232;16836;BMC Chemical Biology;journal;14726769;0.634;Q2;19;7;8;330;14;8;1.8;47.14;United Kingdom;BioMed Central;2001-2012;"Drug Discovery (Q2); Molecular Medicine (Q3)"
233;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.633;Q2;70;185;582;5568;871;570;1.27;30.1;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
234;21194;Pharmacology;journal;00317012, 14230313;0.631;Q2;54;112;212;4257;383;210;1.91;38.01;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
235;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.628;Q2;36;29;99;3060;194;98;1.99;105.52;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
236;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;0.628;Q2;25;24;41;368;48;34;1.31;15.33;United States;Springer USA;2006-ongoing;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
237;20580;Journal of Food Biochemistry;journal;01458884;0.627;Q2;40;51;140;1659;156;140;0.75;32.53;United States;Wiley-Blackwell;1977-ongoing;"Biophysics (Q2); Food Science (Q2); Pharmacology (Q2); Cell Biology (Q3)"
238;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.624;Q2;78;174;632;7139;1116;624;1.75;41.03;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
239;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.622;Q2;65;90;257;2551;519;232;2.03;28.34;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
240;20027;BMC Pharmacology;journal;14712210;0.62;Q2;38;15;49;397;78;48;1.21;26.47;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
241;20770;Drug Delivery;journal;10717544;0.62;Q2;52;50;172;1383;295;170;1.5;27.66;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
242;21229;Drug News and Perspectives;journal;02140934;0.62;Q2;47;70;212;3821;308;209;1.55;54.59;Spain;J.R. Prous;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
243;24578;Mathematical Medicine and Biology;journal;14778599;0.62;Q2;40;26;55;1023;83;54;0.97;39.35;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
244;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0.619;Q2;59;95;249;5061;559;229;2.63;53.27;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2)"
245;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0.618;Q2;107;80;592;3278;1125;582;1.83;40.98;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
246;6400153120;Chinese Medicine;journal;17498546;0.617;Q2;34;24;32;1143;84;30;2.41;47.63;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
247;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0.613;Q2;69;232;767;17522;1708;738;2.44;75.53;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
248;25106;Human and Experimental Toxicology;journal;09603271;0.612;Q2;71;100;336;2368;564;304;1.54;23.68;United States;SAGE Publications;1981-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
249;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0.61;Q2;36;16;67;712;110;66;1.52;44.5;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
250;16067;Reading Teacher;journal;00340561;0.61;Q2;44;68;227;1369;140;225;0.48;20.13;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
251;4000148406;Clinical Toxicology;journal;15563650;0.605;Q2;85;123;431;2991;593;357;1.59;24.32;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
252;11500153306;Recent Patents on Drug Delivery and Formulation;journal;18722113;0.601;Q2;25;9;37;1034;62;37;1.68;114.89;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
253;20026;BMC Clinical Pharmacology;journal;14726904;0.599;Q2;35;18;33;590;70;33;2.27;32.78;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
254;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.597;Q2;72;132;314;5468;451;310;1.45;41.42;Netherlands;Elsevier BV;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
255;29053;Molecular Diversity;journal;1573501X, 13811991;0.597;Q2;54;50;90;3174;275;87;2.17;63.48;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Catalysis (Q3); Physical and Theoretical Chemistry (Q3); Molecular Biology (Q4)"
256;25864;Heterocycles;journal;03855414;0.591;Q2;61;356;1117;11372;1318;1102;1.27;31.94;Netherlands;Elsevier BV;1983, 1985-ongoing;"Analytical Chemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
257;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.589;Q2;25;28;77;2051;156;77;2.14;73.25;United Arab Emirates;Bentham Science Publishers;2006-2015;"Cardiology and Cardiovascular Medicine (Q2); Drug Discovery (Q2); Pharmacology (medical) (Q2)"
258;19700185200;Journal of Natural Medicines;journal;18610293;0.583;Q2;37;62;200;1287;217;197;1.19;20.76;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Organic Chemistry (Q3)"
259;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.579;Q2;55;90;277;2768;449;254;1.75;30.76;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
260;18077;Fitoterapia;journal;0367326X;0.579;Q2;90;104;399;2656;701;397;1.56;25.54;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
261;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.579;Q3;76;90;253;4146;541;246;2.29;46.07;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q3)
262;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.578;Q2;54;74;239;2204;402;235;1.88;29.78;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
263;11700154733;Journal of Biomedical Nanotechnology;journal;15507033;0.577;Q2;64;66;104;2844;132;99;1.33;43.09;United States;American Scientific Publishers;2007-ongoing;"Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
264;21256;Drugs of Today;journal;16993993, 16994019;0.569;Q2;46;63;240;3909;425;234;1.87;62.05;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
265;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.564;Q2;62;81;188;3309;345;186;1.85;40.85;United States;Wiley-Blackwell;1986-ongoing;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
266;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.563;Q2;50;37;173;1237;185;170;0.86;33.43;United States;Marcel Dekker Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
267;21264;Drugs in R and D;journal;11745886;0.56;Q2;39;0;116;0;261;114;2.35;0;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q2)
268;16319;IEEE Transactions on Nanobioscience;journal;15361241;0.56;Q2;55;34;110;1090;236;106;2.05;32.06;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
269;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.555;Q3;56;40;125;2113;249;123;2.14;52.83;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3); Cell Biology (Q4)"
270;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.554;Q2;52;63;222;1426;279;206;1.27;22.63;Germany;Springer Verlag;2010-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
271;130047;Current Drug Discovery Technologies;journal;15701638;0.553;Q2;38;28;85;2842;150;82;1.92;101.5;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q2)
272;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.548;Q2;46;196;627;4672;633;618;1.01;23.84;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
273;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;0.546;Q3;38;0;32;0;62;31;1.76;0;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Cancer Research (Q3); Toxicology (Q3)"
274;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.542;Q3;44;123;148;3197;247;140;1.73;25.99;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
275;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.533;Q3;62;124;248;2750;387;224;1.69;22.18;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
276;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0.53;Q2;46;17;74;891;123;70;1.84;52.41;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3); Virology (Q3)"
277;26370;Molecules;journal;14203049;0.528;Q2;116;407;516;15099;915;502;1.85;37.1;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
278;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.525;Q2;69;33;135;1498;244;134;1.58;45.39;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
279;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.523;Q1;11;0;7;0;10;6;1.67;0;United States;JAI Press;1996, 1999, 2003, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Virology (Q3)"
280;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.523;Q3;42;41;120;1637;204;117;1.55;39.93;United Kingdom;Taylor & Francis;1993-ongoing;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
281;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.52;Q1;35;127;61;3178;38;48;0.79;25.02;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
282;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0.512;Q3;55;69;223;2488;279;213;1.34;36.06;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Oncology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Pharmacology (Q3)"
283;26767;Altex;journal;1868596X, 18688551;0.509;Q3;45;27;134;1043;134;122;1.23;38.63;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
284;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.505;Q3;78;112;422;3546;474;412;1.11;31.66;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
285;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.5;Q3;43;34;90;1287;183;90;1.43;37.85;United States;Begell House;1984-1990, 1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
286;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.496;Q3;58;44;103;1645;104;86;1.34;37.39;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
287;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.488;Q2;35;38;151;836;152;144;0.73;22;United States;Informa Healthcare;2013-ongoing;"Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3)"
288;22411;Inflammopharmacology;journal;09254692, 15685608;0.478;Q3;45;32;132;2045;204;127;1.67;63.91;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (medical) (Q2); Immunology (Q3); Pharmacology (Q3)"
289;21353;Expert Opinion on Therapeutic Patents;journal;13543776;0.477;Q3;61;88;298;7156;333;286;1.14;81.32;United Kingdom;Taylor & Francis;1991-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
290;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.476;Q3;63;299;753;5205;656;746;0.94;17.41;Germany;Springer Verlag;1966-ongoing;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
291;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.47;Q3;30;21;55;374;50;52;1.03;17.81;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q3)"
292;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0.463;Q3;50;92;302;9533;385;294;1.38;103.62;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery (Q3)
293;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.462;Q3;51;57;166;2626;245;160;1.33;46.07;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
294;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.461;Q3;61;180;306;5462;476;300;1.51;30.34;United Kingdom;Taylor & Francis;1985-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
295;13248;Experimental and Toxicologic Pathology;journal;09402993;0.458;Q3;58;50;202;1821;288;196;1.28;36.42;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
296;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0.457;Q3;27;17;72;1430;139;72;1.95;84.12;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3)"
297;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.456;Q3;23;26;26;872;29;26;1.12;33.54;Slovakia;Slovak Toxicology Society SETOX;2010-ongoing;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
298;4700152603;Medicinal Chemistry;journal;15734064;0.453;Q3;39;59;205;1929;350;205;1.59;32.69;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q3)
299;19441;American Journal of Drug Delivery;journal;11759038;0.452;Q3;19;0;28;0;36;24;0;0;United Kingdom;Adis International Ltd.;2004-2006;Pharmacology (Q3)
300;19600166302;Current molecular pharmacology;journal;18744702;0.438;Q3;34;25;23;3406;27;23;1.17;136.24;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
301;144790;Marine Drugs;journal;16603397;0.437;Q3;84;32;64;1749;149;64;2.57;54.66;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q3)
302;21192;Drug Development Research;journal;02724391, 10982299;0.434;Q3;54;57;203;3130;238;192;0.56;54.91;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q3)
303;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.428;Q3;24;21;74;2108;122;68;1.82;100.38;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
304;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.428;Q2;53;36;137;1078;199;128;1.33;29.94;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3); Drug Discovery (Q3)"
305;13671;Biologicals;journal;10958320, 10451056;0.426;Q3;51;61;161;1298;202;144;1.39;21.28;United States;Elsevier Inc.;1990-ongoing;"Medicine (miscellaneous) (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
306;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0.424;Q1;79;186;555;5940;723;543;1.17;31.94;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Cell Biology (Q4); Physiology (Q4)"
307;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.423;Q3;30;36;144;1106;139;141;0.92;30.72;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
308;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.419;Q3;18;5;26;216;33;25;1.61;43.2;United Kingdom;BioMed Central;2003-2011;"Immunology (Q3); Pharmacology (Q3)"
309;19958;Archives of Pharmacal Research;journal;02536269;0.409;Q3;75;236;596;6602;738;594;1.23;27.97;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3)"
310;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.409;Q3;40;186;451;6150;544;428;1.39;33.06;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
311;19398;Acta Pharmaceutica;journal;13300075;0.405;Q2;49;40;104;708;163;104;1.39;17.7;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
312;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.4;Q3;22;9;152;431;105;138;0.94;47.89;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Molecular Medicine (Q3)"
313;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.394;Q3;33;30;81;829;146;81;1.39;27.63;United Kingdom;BioMed Central;2006-ongoing;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
314;29947;Journal of Chemotherapy;journal;1120009X;0.393;Q3;45;111;382;2776;336;349;1.13;25.01;United Kingdom;Maney Publishing;1989-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
315;27210;In Vivo;journal;0258851X;0.392;Q3;54;114;360;3722;401;347;1.12;32.65;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
316;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.389;Q3;38;52;92;1731;129;91;1.38;33.29;United States;Marcel Dekker Inc.;1977-ongoing;"Chemical Health and Safety (Q1); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
317;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.387;Q1;32;17;42;640;57;40;1.63;37.65;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
318;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.386;Q3;55;100;229;2751;220;170;1.12;27.51;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Medical Laboratory Technology (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
319;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.382;Q2;22;21;87;1678;101;87;0.98;79.9;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q3)"
320;24071;Metal-Based Drugs;journal;07930291, 16875486;0.378;Q3;33;3;21;94;30;19;1.58;31.33;Egypt;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q3); Inorganic Chemistry (Q3); Pharmacology (Q3); Toxicology (Q3)"
321;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.378;Q3;47;54;222;3032;259;220;1.08;56.15;Spain;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
322;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.375;Q3;58;113;338;2172;250;302;0.62;19.22;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
323;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.372;Q1;19;10;38;345;66;37;1.25;34.5;United Kingdom;BioMed Central;2002-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
324;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.369;Q2;54;52;140;1637;206;140;1.37;31.48;United States;John Wiley & Sons Inc.;1979-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
325;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.367;Q3;32;21;113;769;123;110;1.2;36.62;United States;Taylor and Francis;2004-ongoing;"Toxicology (Q3); Immunology (Q4)"
326;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.364;Q3;21;25;76;2808;80;73;1.17;112.32;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Infectious Diseases (Q3); Pharmacology (Q3)"
327;18800156720;Dissolution Technologies;journal;1521298X;0.364;Q2;28;15;57;199;32;44;0.58;13.27;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q2)
328;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.356;Q3;52;82;155;2893;164;150;0.96;35.28;United States;SAGE Publications;1985-ongoing;"Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
329;23489;Chemical Speciation and Bioavailability;journal;09542299;0.351;Q3;25;28;56;930;45;54;0.78;33.21;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
330;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.351;Q1;43;97;287;5509;341;274;1.28;56.79;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Safety Research (Q2)"
331;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.348;Q3;25;30;93;730;113;91;1.3;24.33;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
332;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.347;Q2;50;149;571;2725;551;568;0.74;18.29;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
333;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0.346;Q2;33;53;132;1070;95;124;0.75;20.19;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
334;5800173386;Current Drug Safety;journal;15748863;0.343;Q3;31;37;101;1814;157;95;1.63;49.03;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
335;21717;Die Pharmazie;journal;00317144;0.338;Q2;56;106;550;2427;513;544;0.92;22.9;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
336;19300156901;Dose-Response;journal;15593258;0.333;Q3;30;19;21;1289;31;21;1.48;67.84;United States;International Dose-Response Society;2008-ongoing;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
337;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.333;Q3;18;16;87;307;63;76;0.53;19.19;Finland;Nordic Association of Occupational Safety and Health (NOROSH);2005-2011, 2016-ongoing;"Geography, Planning and Development (Q2); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
338;22456;International Journal of Pharmacy Practice;journal;09617671;0.332;Q2;32;63;126;1368;76;113;0.53;21.71;United Kingdom;Wiley-Blackwell;1991-ongoing;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q3)"
339;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.331;Q2;52;134;418;2052;359;386;0.84;15.31;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Education (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
340;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.331;Q3;45;127;351;3282;613;338;1.97;25.84;Italy;SAGE Publications Inc.;1989-ongoing;"Immunology and Allergy (Q3); Pharmacology (Q3); Immunology (Q4)"
341;10900153328;Frontiers in Drug Design and Discovery;book series;15672042;0.33;Q2;8;17;41;2016;30;39;1.09;118.59;United Arab Emirates;Bentham Science Publishers;2006-2009;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
342;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.328;Q2;53;188;338;5427;302;335;0.75;28.87;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
343;5400152628;Brazilian Journal of Pharmacognosy;journal;0102695X, 1981528X;0.326;Q2;37;128;198;4069;520;189;2.75;31.79;Brazil;Sociedade Brasileira de Farmacognosia;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
344;15340;Developments in Biologicals;book series;14246074;0.325;Q3;35;0;318;0;281;311;0.65;0;Switzerland;S. Karger AG;2000-2008, 2010-2013;"Pharmacology (Q3); Biomaterials (Q4); Immunology (Q4)"
345;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.325;Q2;45;130;393;3850;480;388;1.2;29.62;China;Zhejiang University Press;2005-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
346;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;0.324;Q3;41;27;134;369;118;114;1.04;13.67;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
347;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.321;Q3;42;52;172;1789;159;169;0.81;34.4;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3); Immunology (Q4)"
348;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0.319;Q3;30;18;96;935;70;94;0.91;51.94;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q3)
349;21811;Farmacia Hospitalaria;journal;11306343;0.317;Q3;21;67;236;1088;112;125;0.69;16.24;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
350;4100151616;Supportive Cancer Therapy;journal;15432912;0.314;Q3;13;0;66;0;66;55;1.42;0;United States;Cancer Information Group;2006-2007;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
351;5800173401;Current Bioactive Compounds;journal;15734072;0.313;Q2;21;28;42;2102;41;38;1.08;75.07;United Arab Emirates;Bentham Science Publishers;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
352;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.313;Q2;37;37;92;1202;72;88;0.79;32.49;Netherlands;Elsevier BV;2005-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
353;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;0.311;Q3;36;41;130;1123;94;127;0.64;27.39;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
354;17700155034;Natural product communications;journal;15559475, 1934578X;0.311;Q3;35;303;672;8278;483;661;0.72;27.32;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
355;35190;Revista Espanola de Quimioterapia;journal;02143429;0.311;Q3;23;46;143;1111;105;129;0.74;24.15;Spain;Sociedad Española de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
356;25144;Journal of Health Science;journal;13475207, 13449702;0.308;Q4;42;133;348;3912;280;346;0.75;29.41;Kenya;African Forum for Health Sciences;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q4)"
357;25171;Mycotoxin Research;journal;01787888;0.306;Q4;31;31;101;1041;82;89;0.72;33.58;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q3); Microbiology (Q3); Toxicology (Q4)"
358;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0.302;Q3;33;48;119;1174;68;119;0.41;24.46;United Kingdom;BioMed Central;2000-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
359;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.3;Q3;26;22;160;901;112;144;0.54;40.95;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
360;4700152769;Pharmacopeial Forum;journal;03634655;0.298;Q3;16;24;69;218;14;35;0.61;9.08;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Pharmacy (Q1); Drug Guides (Q3); Pharmacology (Q3)"
361;20065;BioPharm International;journal;1542166X;0.297;Q2;25;102;352;441;112;303;0.38;4.32;United States;UBM Medica Periodical Publication;2002-ongoing;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
362;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.296;Q3;8;0;15;0;3;13;0.23;0;United States;Elsevier Inc.;2004-2005, 2008, 2012-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3)"
363;24097;Journal of the Indian Chemical Society;journal;00194522;0.29;Q3;31;165;742;3290;283;733;0.37;19.94;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Drug Discovery (Q3); Electrochemistry (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
364;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.289;Q2;35;147;413;2181;238;413;0.54;14.84;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
365;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.286;Q3;41;88;391;1837;245;383;0.58;20.88;United States;John Wiley & Sons Inc.;1976-ongoing;"Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Biochemistry (Q4); Spectroscopy (Q4)"
366;20578;Journal of Food and Drug Analysis;journal;10219498;0.284;Q3;41;32;196;857;108;190;0.52;26.78;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q3); Pharmacology (Q3)"
367;110097;Food and Drug Law Journal;journal;1064590X;0.282;Q3;18;32;115;5476;42;115;0.39;171.13;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
368;130038;Letters in Drug Design and Discovery;journal;15701808;0.281;Q2;28;86;269;2240;190;267;0.8;26.05;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
369;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0.276;Q2;38;52;178;2001;95;175;0.56;38.48;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q2)
370;21265;Drugs of the Future;journal;03778282;0.275;Q3;40;110;346;7047;222;340;0.57;64.06;Spain;Prous Science;1978-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
371;19383;Fluoride - Quarterly Reports;journal;00154725;0.272;Q4;41;28;146;618;95;137;0.52;22.07;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
372;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.272;Q4;35;64;226;2230;184;212;0.9;34.84;United Kingdom;Taylor & Francis;1991-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
373;21100470510;Drug Research;journal;21949379, 21949387;0.271;Q3;56;114;356;2240;245;352;0.65;19.65;Germany;Thieme;1972, 2013-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
374;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0.27;Q2;43;156;592;3884;296;588;0.48;24.9;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
375;21211;Pharmacy Education;journal;14772701, 15602214;0.269;Q2;15;10;87;164;42;87;0.44;16.4;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmaceutical Science (Q2); Pharmacy (Q2); Education (Q3)"
376;73430;Pharmaceutical Technology;journal;15432521;0.268;Q2;35;184;570;721;106;431;0.23;3.92;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q2); Biophysics (Q4)"
377;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.267;Q4;21;24;22;627;15;21;0.71;26.13;United Kingdom;Taylor & Francis;2008-ongoing;"Food Science (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
378;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0.267;Q3;23;69;153;1868;68;153;0.35;27.07;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
379;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0.265;Q3;34;35;93;716;69;91;0.74;20.46;France;Springer Paris;1976-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
380;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0.264;Q2;15;38;123;828;45;120;0.42;21.79;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q2)
381;144963;Drug Discovery Today: Disease Models;journal;17406757;0.264;Q3;23;22;137;950;63;121;0.45;43.18;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q4)"
382;21207;Drug Discovery Today: Technologies;journal;17406749;0.264;Q3;41;16;93;606;84;84;0.24;37.88;Netherlands;Elsevier BV;2004-ongoing;"Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q4)"
383;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0.254;Q2;29;229;617;4407;300;616;0.5;19.24;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
384;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;0.251;Q2;44;71;62;2966;17;55;0.31;41.77;United States;Springer New York LLC;2008-ongoing;"Pharmaceutical Science (Q2); Cardiology and Cardiovascular Medicine (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Medicine (Q4)"
385;22854;Yakugaku Zasshi;journal;00316903;0.247;Q2;37;191;579;4535;382;554;0.63;23.74;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
386;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.245;Q3;52;80;269;1290;182;205;0.74;16.13;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
387;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.245;Q4;8;25;70;455;11;70;0.13;18.2;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
388;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.243;Q4;22;51;156;1426;74;145;0.51;27.96;United Kingdom;BioMed Central;2006-ongoing;"Animal Science and Zoology (Q3); Infectious Diseases (Q3); Parasitology (Q4); Toxicology (Q4)"
389;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.241;Q3;19;35;79;908;45;79;0.43;25.94;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
390;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.241;Q3;9;27;101;321;13;99;0.15;11.89;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q3)
391;21102;Pharmaceutical Journal;journal;00316873;0.239;Q3;25;1058;3047;972;128;706;0.13;0.92;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
392;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.235;Q2;26;20;66;1174;73;66;1.02;58.7;Spain;Elsevier Espana;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Agricultural and Biological Sciences (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
393;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.232;Q3;35;75;189;2298;149;187;0.81;30.64;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q3)
394;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0.231;Q3;9;24;79;620;26;79;0.31;25.83;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Clinical Psychology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
395;79053;Natural Product Sciences;journal;12263907;0.231;Q3;22;46;143;1022;60;143;0.4;22.22;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q4)"
396;11100153314;Frontiers in Medicinal Chemistry;book series;15740889;0.226;Q3;6;29;27;4600;12;26;0;158.62;United Arab Emirates;Bentham Science Publishers;2006, 2009-2010;"Drug Discovery (Q3); Molecular Medicine (Q4); Organic Chemistry (Q4)"
397;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.222;Q3;45;56;182;1367;97;145;0.55;24.41;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q3); Physiology (medical) (Q3); Physiology (Q4)"
398;4500151530;Personalized Medicine;journal;17410541;0.222;Q3;24;69;168;2470;97;141;0.74;35.8;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
399;22357;IDrugs : the investigational drugs journal;journal;13697056;0.22;Q3;32;149;484;1165;230;480;0.48;7.82;United Kingdom;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
400;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.22;Q3;8;55;101;807;14;94;0.22;14.67;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
401;22908;Chinese Pharmacological Bulletin;journal;10011978;0.217;Q3;15;405;1079;5823;681;1079;0.69;14.38;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q3)
402;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.216;Q3;16;70;40;1918;16;33;0.48;27.4;Chile;Universidad de Santiago de Chile;2008-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3); Plant Science (Q3); Drug Discovery (Q4)"
403;11200153563;Drug Metabolism Letters;journal;18723128;0.216;Q3;23;21;97;530;60;95;0.63;25.24;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Biochemistry (medical) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4)"
404;25253;Blutalkohol;journal;00065250;0.215;Q4;13;28;75;421;15;70;0.22;15.04;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
405;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.213;Q3;17;28;25;2321;15;25;0.6;82.89;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
406;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X;0.212;Q4;21;21;49;2109;27;49;0.55;100.43;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
407;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.211;Q3;17;24;37;993;18;35;0.58;41.38;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Sports Science (Q4)"
408;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.211;Q3;25;0;64;0;49;62;0.45;0;United States;The Haworth Herbal Press;2001-2007;"Pharmacology (Q3); Biochemistry (Q4)"
409;5800173394;Current Drug Therapy;journal;15748855;0.209;Q2;14;27;50;1744;28;48;0.58;64.59;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
410;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.209;Q3;11;22;50;522;11;49;0.12;23.73;Turkey;Turkish Pharmacists Association;2006-ongoing;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
411;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.208;Q3;30;27;66;935;37;66;0.53;34.63;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4); Physiology (Q4)"
412;22375;Indian Drugs;journal;0019462X;0.207;Q3;30;142;454;2531;122;452;0.2;17.82;India;Scientific Publishers;1989-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
413;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.206;Q3;35;79;312;1692;147;306;0.43;21.42;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
414;4700152607;Current Enzyme Inhibition;journal;15734080;0.205;Q4;15;20;74;2319;42;74;0.69;115.95;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
415;144613;Journal of Generic Medicines;journal;17411343;0.205;Q3;14;35;125;470;27;117;0.13;13.43;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
416;21083;Pharmaceutical Care Espana;journal;11396202;0.204;Q3;9;26;86;430;10;68;0.12;16.54;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
417;21758;Prescrire International;journal;11677422;0.203;Q3;11;179;485;1262;100;387;0.22;7.05;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
418;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.202;Q2;32;100;216;2962;95;206;0.28;29.62;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
419;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.2;Q3;23;65;154;2637;29;146;0.2;40.57;United States;Current Medicine Group;2007-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
420;21810;Farmacia;journal;00148237;0.2;Q2;19;58;84;861;31;84;0.37;14.84;Romania;Uniunea Societatilor De Stiinte Medicale;1973-1987, 2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
421;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.2;Q4;9;29;87;748;28;86;0.28;25.79;Japan;Medical and Pharmaceutical Society for WAKAN-YAKU;2004, 2006-2007;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
422;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.198;Q4;26;53;114;1678;55;114;0.68;31.66;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
423;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.198;Q3;4;64;104;1577;15;104;0.17;24.64;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
424;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.197;Q3;25;42;97;1402;50;96;0.48;33.38;United States;Begell House;2005-ongoing;"Applied Microbiology and Biotechnology (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
425;21100301409;Issues in Toxicology;book series;17577179;0.197;Q3;12;18;51;1596;15;47;0.32;88.67;United Kingdom;Royal Society of Chemistry;2007-ongoing;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
426;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.195;Q3;17;172;673;867;42;647;0.07;5.04;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
427;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0.194;Q4;27;78;301;1327;90;300;0.27;17.01;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
428;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.193;Q4;9;56;141;989;15;140;0.13;17.66;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q3); Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
429;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.192;Q3;19;36;99;3866;35;88;0.28;107.39;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4)"
430;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.192;Q3;17;0;55;0;34;46;0.81;0;United Kingdom;Librapharm Ltd.;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
431;11200153304;Future HIV Therapy;journal;17469600;0.191;Q3;8;0;57;0;16;46;0.35;0;United Kingdom;Future Medicine Ltd.;2008-2009;"Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4); Virology (Q4)"
432;58808;Pharmaceutical Care and Research;journal;16712838;0.191;Q3;7;138;332;1161;31;330;0.09;8.41;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
433;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.19;Q3;9;157;346;1166;25;317;0.08;7.43;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Pharmacology (nursing) (Q2); Pharmacy (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
434;130031;Journal of Toxicologic Pathology;journal;09149198;0.188;Q4;20;12;93;424;29;93;0.35;35.33;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
435;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.187;Q4;37;56;42;4224;22;34;0.65;75.43;United Kingdom;Future Medicine Ltd.;2008-ongoing;"Biochemistry (medical) (Q3); Clinical Biochemistry (Q4); Drug Discovery (Q4)"
436;21798;Farmaceutski Glasnik;journal;00148202;0.187;Q3;5;73;112;349;6;97;0.06;4.78;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
437;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;0.186;Q2;9;0;50;0;20;50;0;0;United Kingdom;Blackwell Publishing Inc.;2005-2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
438;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.184;Q3;14;19;117;1798;36;105;0.32;94.63;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
439;18384;Medicinal Chemistry Research;journal;10542523;0.184;Q2;38;65;270;1699;103;269;0.97;26.14;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
440;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.184;Q4;33;0;59;0;36;53;0.32;0;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
441;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.182;Q3;37;6;18;0;12;18;0;0;United States;PJD Publications Ltd.;1994-2007, 2009;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
442;19446;American Pharmaceutical Review;journal;10998012;0.181;Q3;20;68;314;1162;88;313;0.24;17.09;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q3)
443;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0.18;Q3;18;109;212;523;63;197;0.3;4.8;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
444;9800153137;Trastornos Adictivos;journal;15750973;0.177;Q3;8;35;58;751;22;44;0.5;21.46;Spain;Elsevier Doyma;2007-2012;"Pharmacology (Q3); Psychiatry and Mental Health (Q3)"
445;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.175;Q3;21;0;100;0;26;100;0;0;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
446;23171;Korean Journal of Pharmacognosy;journal;02533073;0.175;Q3;14;64;189;1476;48;189;0.25;23.06;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
447;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.172;Q3;16;34;107;690;22;106;0.16;20.29;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q3)
448;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.172;Q3;14;46;117;1370;25;117;0.22;29.78;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q3)
449;22906;Journal of China Pharmaceutical University;journal;10005048;0.171;Q3;13;96;298;1323;55;298;0.2;13.78;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
450;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.167;Q3;22;45;126;1217;48;121;0.36;27.04;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
451;19600162009;Advances in Molecular Toxicology;book series;18720854;0.166;Q3;10;7;14;842;8;12;0.71;120.29;Netherlands;Elsevier BV;2006, 2008-ongoing;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
452;22934;Chinese Pharmaceutical Journal;journal;10012494;0.166;Q3;19;429;1364;4754;238;1364;0.16;11.08;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
453;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.164;Q2;15;35;144;550;26;120;0.24;15.71;United States;SAGE Publications Inc.;2000-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
454;5800179590;Pharmacologyonline;journal;18278620;0.164;Q3;21;350;358;8669;122;358;0.34;24.77;Italy;SILAE;2007-ongoing;"Pharmacology (Q3); Drug Discovery (Q4)"
455;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;0.163;Q4;29;58;275;1615;89;275;0.38;27.84;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology (Q4)
456;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0.162;Q2;14;23;82;757;20;72;0.16;32.91;Hungary;Neuroline;2004-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
457;20684;Current Pharmacogenomics;journal;15701603;0.16;Q4;11;0;53;0;22;53;0.48;0;United Arab Emirates;Bentham Science Publishers;2004-2007;"Genetics (Q4); Pharmacology (Q4)"
458;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.16;Q3;9;43;55;663;15;53;0.28;15.42;Netherlands;IOS Press;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
459;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.16;Q3;26;592;1611;6834;394;1611;0.2;11.54;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
460;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.159;Q4;11;9;43;52;14;43;0.31;5.78;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
461;130089;Toxin Reviews;journal;15569543, 15569551;0.158;Q4;38;32;62;1815;25;58;0.52;56.72;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q4)
462;19700175230;Drug Design, Development and Therapy;journal;11778881;0.157;Q3;48;21;30;1056;11;27;0.41;50.29;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
463;21795;Farmaceuticky Obzor;journal;00148172;0.156;Q3;7;31;96;616;8;93;0.05;19.87;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q3)
464;21127;Pharmaceutical Technology Europe;journal;17537967;0.156;Q3;16;92;301;445;27;230;0.11;4.84;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q3)
465;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.155;Q4;9;0;10;0;3;9;0;0;Singapore;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
466;73076;Drug Discovery World;journal;14694344;0.155;Q4;10;44;94;362;27;85;0.34;8.23;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
467;22338;Hospital Pharmacy;journal;00185787;0.155;Q4;21;121;406;1567;57;355;0.17;12.95;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
468;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.152;Q3;7;0;47;0;7;36;0.11;0;United States;Haworth Press Inc.;2003-2008;"Pharmaceutical Science (Q3); Health Policy (Q4); Pharmacology (Q4)"
469;10300153301;Expert Review of Clinical Pharmacology;journal;17512433;0.151;Q3;32;58;58;5034;26;50;0.52;86.79;United Kingdom;Taylor & Francis;2008-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
470;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0.149;Q4;15;35;133;565;51;120;0.45;16.14;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
471;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0.148;Q4;13;152;400;2866;27;400;0.07;18.86;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
472;13000154717;Current Topics in Toxicology;journal;09728228;0.148;Q4;6;5;11;240;4;11;0.36;48;India;Research Trends;2007-2009, 2011-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
473;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.147;Q3;14;12;37;303;9;37;0.21;25.25;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
474;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.146;Q4;2;0;11;0;2;10;0.2;0;Netherlands;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
475;19978;Ars Pharmaceutica;journal;00042927, 23409894;0.145;Q3;18;18;87;451;22;87;0.25;25.06;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
476;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.145;Q3;31;47;44;942;18;40;0.45;20.04;Iran;Shaheed Behesti University of Medical Sciences and Health;2008-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
477;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.145;Q4;22;36;114;592;32;114;0.39;16.44;United States;Western Pharmacology Society, Inc.;1960-1969, 1973-2011;Pharmacology (Q4)
478;145693;Canadian Pharmacists Journal;journal;17151635;0.143;Q3;18;70;350;746;30;199;0.12;10.66;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
479;22205;Saudi Pharmaceutical Journal;journal;13190164;0.143;Q3;36;40;86;1135;29;86;0.29;28.38;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
480;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.142;Q4;5;9;39;173;5;38;0.14;19.22;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Pharmacology (medical) (Q3); Dentistry (miscellaneous) (Q4); Pharmacology (Q4)"
481;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.141;Q4;12;25;30;759;5;30;0.17;30.36;United Kingdom;Inderscience Enterprises;2008-ongoing;"Computer Science Applications (Q4); Drug Discovery (Q4)"
482;21227;Pharmacy in Practice;journal;13581538;0.141;Q4;5;26;157;313;4;133;0.03;12.04;United Kingdom;Medicom Publishing;1995-2009;"Pharmacology (medical) (Q3); Pharmacy (Q3); Health Policy (Q4); Pharmacology (Q4)"
483;19700174889;Drug Target Insights;journal;11773928;0.14;Q3;10;1;14;45;4;14;0.29;45;New Zealand;Libertas Academica;2008-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Clinical Biochemistry (Q4)"
484;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.14;Q3;17;56;71;1064;14;67;0.21;19;India;Association of Pharmaceutical Teachers of India;2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
485;10900153302;Biomarker Insights;journal;11772719;0.139;Q4;24;8;33;282;10;33;0.3;35.25;New Zealand;Libertas Academica;2008-ongoing;"Biochemistry (medical) (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
486;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0.139;Q4;34;40;106;1194;31;100;0.27;29.85;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
487;11200153306;Journal of Pharmacology and Toxicology;journal;1816496X;0.139;Q3;15;18;48;606;12;48;0.25;33.67;United States;Academic Journals Inc.;2008-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
488;11900154394;Oriental Journal of Chemistry;journal;0970020X, 22315039;0.139;Q4;18;212;187;3562;18;187;0.1;16.8;India;Scientific Publishers;2008-ongoing;"Biochemistry (Q4); Chemistry (miscellaneous) (Q4); Drug Discovery (Q4); Environmental Chemistry (Q4)"
489;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.139;Q4;26;151;473;2311;85;472;0.14;15.3;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
490;21412;Zeitschrift für Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.139;Q4;12;68;186;912;32;110;0.3;13.41;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
491;19700180757;Advances in Phytomedicine;book series;1572557X;0.138;Q4;12;0;43;0;17;39;0;0;Netherlands;Elsevier BV;2002, 2006;"Drug Discovery (Q4); Plant Science (Q4)"
492;19700175819;Patient Preference and Adherence;journal;1177889X;0.138;Q3;37;39;69;1479;17;69;0.25;37.92;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Social Sciences (miscellaneous) (Q3); Health Policy (Q4)"
493;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.138;Q3;34;52;65;1392;23;65;0.37;26.77;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
494;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.137;Q4;11;44;228;979;41;228;0.18;22.25;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
495;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.137;Q4;24;26;95;616;31;95;0.19;23.69;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
496;22977;Journal de Pharmacie de Belgique;journal;00472166;0.135;Q3;12;18;65;277;8;60;0.07;15.39;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
497;13718;Pharmaceutical Engineering;journal;02738139;0.135;Q3;13;50;153;352;11;136;0.08;7.04;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q3)
498;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.135;Q3;5;46;118;182;6;118;0.07;3.96;United States;Russell Publishing LLC;2010-ongoing;"Pharmaceutical Science (Q3); Health Policy (Q4)"
499;5400152620;American Journal of Pharmacology and Toxicology;journal;15574970, 15574962;0.134;Q3;16;16;45;607;19;45;0.42;37.94;United States;Science Publications;2007-2016 (cancelled);"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
500;17700156431;Handbook of Analytical Separations;book series;15677192;0.134;Q3;11;0;32;0;6;0;0;0;Netherlands;Elsevier BV;2000-2001, 2003-2004, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Analytical Chemistry (Q4); Environmental Chemistry (Q4); Pathology and Forensic Medicine (Q4)"
501;4000151610;International Journal of Neuroprotection and Neurogeneration;journal;17451183, 17451191;0.134;Q4;5;0;55;0;13;48;0.13;0;United Kingdom;RPA Publishers.;2006-2008;"Neurology (clinical) (Q4); Pharmacology (Q4)"
502;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.134;Q4;18;15;101;452;41;101;0.24;30.13;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology (Q4)
503;19200156706;Pharmacognosy Magazine;journal;09731296, 09764062;0.134;Q4;29;86;75;2026;28;71;0.39;23.56;India;Medknow Publications;2008-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
504;130170;Phytotherapie;journal;17652847, 16248597;0.134;Q4;12;52;164;896;18;121;0.13;17.23;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
505;21800;Farmacevtski Vestnik;journal;00148229;0.132;Q4;4;49;109;1069;5;106;0.05;21.82;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4)"
506;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.131;Q4;26;61;65;2033;18;65;0.28;33.33;South Korea;Korean Society of Applied Pharmacology;2008-ongoing;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
507;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.131;Q4;5;64;246;456;5;242;0.02;7.13;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
508;22979;Journal of Applied Therapeutic Research;journal;10292659;0.131;Q4;7;10;21;215;8;21;0.44;21.5;United Kingdom;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
509;80593;Journal of Medicinal Plants;journal;16840240;0.131;Q4;16;57;147;1511;24;147;0.12;26.51;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
510;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.131;Q4;12;92;215;1085;30;171;0.19;11.79;United Kingdom;John Wiley & Sons Ltd.;1972-2012;"Pharmacology (medical) (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
511;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0.13;Q4;8;29;99;1093;14;96;0.15;37.69;Spain;Real Academia Nacional de Farmacia;2004-2005;"Pharmacology (medical) (Q3); Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4)"
512;19700174893;Dhaka University Journal of Pharmaceutical Sciences;journal;18161839, 18161820;0.13;Q4;10;29;58;482;17;58;0.29;16.62;Bangladesh;University of Dhaka;2007-ongoing;"Pharmacology (medical) (Q3); Pharmaceutical Science (Q4)"
513;19700175108;Drug Delivery System;journal;09135006;0.13;Q4;7;29;88;706;10;88;0.12;24.34;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
514;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0.13;Q4;10;31;59;963;15;58;0.26;31.06;France;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmaceutical Science (Q4)"
515;23107;Journal of Pharmacy Technology;journal;87551225;0.13;Q4;9;27;95;702;9;90;0.11;26;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q4)
516;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.129;Q4;15;17;45;292;3;45;0.08;17.18;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q4)
517;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.129;Q4;9;22;61;874;6;61;0.05;39.73;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
518;23009;Journal of Clinical Research;journal;13695207;0.129;Q4;11;2;5;23;1;5;0.33;11.5;United Kingdom;Brookwood Medical Publications Ltd;1998-2009;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
519;19700175149;African Journal Biomedical Research;journal;11195096;0.128;Q3;15;0;48;0;13;47;0.28;0;Nigeria;Bioline International;2008, 2010-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
520;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;0.127;Q3;12;0;225;0;53;223;0.24;0;Germany;Springer Verlag;2006-2008;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biotechnology (Q4); Chemistry (miscellaneous) (Q4)"
521;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.126;Q4;13;237;841;3224;100;841;0.11;13.6;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
522;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.125;Q4;6;69;110;257;5;105;0.05;3.72;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2007-2010, 2012-ongoing;Pharmaceutical Science (Q4)
523;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.125;Q4;13;89;275;1388;24;274;0.1;15.6;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
524;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.125;Q4;8;19;90;469;5;72;0.06;24.68;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
525;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.123;Q3;5;16;29;471;5;27;0.19;29.44;Switzerland;Springer International Publishing AG;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
526;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.123;Q4;18;169;128;3300;23;128;0.18;19.53;India;Rasayan Journal;2009-ongoing;"Chemical Engineering (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4); Chemistry (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
527;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.123;Q4;11;34;64;585;5;56;0.09;17.21;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
528;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.122;Q4;11;1;1;36;0;1;0;36;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
529;17716;Quality Assurance Journal;journal;10991786, 10878378;0.122;Q4;7;21;53;202;8;43;0.24;9.62;United States;John Wiley & Sons Inc.;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
530;19700174969;Archives of Drug Information;journal;17535174;0.121;Q4;10;10;14;237;2;13;0.15;23.7;United States;John Wiley & Sons Inc.;2008-2011;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
531;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0.121;Q4;25;99;341;1176;28;230;0.12;11.88;India;Medknow Publications;1996-1999, 2002-ongoing;"Anesthesiology and Pain Medicine (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
532;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148;0.119;Q4;20;26;17;2466;3;17;0.18;94.85;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Biochemistry (medical) (Q4); Drug Discovery (Q4); Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Medicine (miscellaneous) (Q4)"
533;144879;Toxicology International;journal;09716580;0.119;Q4;21;14;63;251;6;62;0.09;17.93;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
534;9100153105;Current Topics in Pharmacology;journal;09724559;0.118;Q4;4;15;52;1247;8;52;0.15;83.13;India;Research Trends;2006-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
535;15842;Journal of Applied Research;journal;1537064X;0.118;Q4;18;21;91;490;25;82;0.31;23.33;United States;Therapeutic Solutions LLC;2001-2014;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
536;21142;Pharmaceutisch Weekblad;journal;00316911;0.118;Q4;9;384;1362;444;10;712;0.02;1.16;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
537;21100197929;Toxicological Research;journal;19768257;0.118;Q4;20;34;42;1079;5;42;0.12;31.74;South Korea;Korean Association of Medical Journal Editors;2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
538;22358;U.S. Pharmacist;journal;01484818;0.117;Q4;7;112;332;2008;30;311;0.1;17.93;United States;Jobson Publishing LLC;1979, 1990-1996, 2007-ongoing;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
539;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0.116;Q4;23;57;131;1860;14;130;0.09;32.63;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q4); Physiology (Q4)"
540;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.114;Q4;13;76;260;782;27;260;0.09;10.29;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
541;5200152604;Pharma Times;journal;00316849;0.114;Q4;10;92;158;439;5;105;0.05;4.77;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
542;4000151703;Core Evidence;journal;15551741, 1555175X;0.113;Q4;19;21;36;1223;6;36;0.21;58.24;United States;Core Medical Pub;2005-ongoing;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
543;19399;Acta Pharmaceutica Hungarica;journal;00016659;0.112;Q4;12;17;72;527;13;72;0.15;31;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
544;16893;Biogenic Amines;journal;15693910, 01688561;0.112;Q4;14;0;50;0;10;49;0.23;0;Netherlands;V S P;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
545;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.112;Q4;3;75;216;368;3;209;0.02;4.91;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
546;19700174992;European Journal of Oncology Pharmacy;journal;20327072, 17833914;0.112;Q4;3;26;17;125;1;15;0.07;4.81;Belgium;Pharma Publishing and Media Europe;2008-ongoing;"Oncology (Q4); Pharmacology (Q4)"
547;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.111;Q4;14;24;73;1031;4;72;0.04;42.96;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q4)
548;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.111;Q4;3;21;56;278;1;54;0;13.24;Belgium;Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
549;21716;Pharmazeutische Zeitung;journal;00317136;0.111;Q4;7;496;1283;1397;17;506;0.02;2.82;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
550;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.11;Q4;2;24;87;205;2;73;0.05;8.54;Netherlands;Elsevier BV;2005-2012;Pharmaceutical Science (Q4)
551;19700174886;Arzneimitteltherapie;journal;07236913;0.11;Q4;6;138;162;1012;7;69;0.1;7.33;Germany;Wissenschaftliche Verlagsgesellschaft;2008-ongoing;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
552;22887;Chinese Journal of Antibiotics;journal;10018689;0.11;Q4;10;162;527;1926;28;526;0.07;11.89;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
553;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;0.11;Q4;40;33;19;2252;7;13;0.54;68.24;United Kingdom;SAGE Publications;2008-ongoing;"Neurology (Q4); Neurology (clinical) (Q4); Pharmacology (Q4)"
554;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.109;Q4;3;131;129;2871;9;126;0.07;21.92;China;Chinese Journal of Cancer Biotheraphy;2008-ongoing;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
555;11800154521;ICBPE 2006 - Proceedings of the 2006 International Conference on Biomedical and Pharmaceutical Engineering;conference and proceedings;00002006;0.109;-;8;0;124;0;12;123;0;0;United States;;2006;"Biomedical Engineering; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
556;22514;Japanese Journal of Chemotherapy;journal;13407007;0.109;Q4;12;50;119;772;9;119;0.05;15.44;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
557;12100156823;5th PCIC Europe 2008: Petroleum and Chemical Industry Conference Europe;conference and proceedings;00002008;0.108;-;5;0;29;0;5;28;0.18;0;United States;;2008;"Chemical Engineering (miscellaneous); Electrical and Electronic Engineering; Geochemistry and Petrology; Pharmaceutical Science"
558;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.108;Q4;4;111;199;1481;10;199;0.05;13.34;China;China Pharmaceutical University;2007-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
559;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0.108;Q4;18;25;54;367;1;48;0;14.68;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
560;21243;Pharmacy times;trade journal;00030627;0.108;Q4;8;199;433;591;15;383;0.04;2.97;United States;Romaine Pierson Publishers;1947-1949, 1975, 1977-1987, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
561;19700174966;Pharmakeftiki;journal;11054999;0.108;Q4;2;13;17;751;1;15;0.07;57.77;Greece;Papathanasopoulos;2008-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
562;19700174922;Chinese Journal of New Drugs;journal;10033734;0.107;Q4;9;454;565;5099;28;565;0.05;11.23;China;Chinese Journal of New Drugs Co. Ltd.;2008-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
563;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;0.107;Q4;5;5;25;79;2;25;0.08;15.8;Taiwan;Pharmaceutical Society of Taiwan;2007, 2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
564;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.106;Q4;17;103;392;1954;23;389;0.05;18.97;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
565;19700175031;Research Journal of Pharmacology;journal;18159362, 19936109;0.106;Q4;7;12;12;400;3;12;0.25;33.33;Pakistan;Medwell Online;2008-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
566;86688;Acta Toxicologica;journal;17316383;0.105;Q4;7;0;38;0;2;35;0.05;0;Poland;Instytut Medycyny Pracy im. Jerzego Nofera/Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
567;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.105;Q4;22;19;57;816;5;55;0.09;42.95;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
568;21867;Geneesmiddelenbulletin;journal;03044629;0.105;Q4;6;58;175;215;2;25;0.07;3.71;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
569;72755;Phytomedica;journal;09723293;0.105;Q4;4;0;45;0;3;45;0;0;India;Scientific Publishers;1999-2006;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
570;25196;Revista Brasileira de Toxicologia;journal;14152983;0.105;Q4;6;6;35;220;3;34;0.05;36.67;Brazil;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
571;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.104;Q4;6;29;128;0;7;128;0.03;0;Spain;Real Academia Nacional de Medicina;1949-2011;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
572;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;book series;18715125;0.104;Q4;15;1;14;0;0;3;0;0;United States;Elsevier Inc.;2001-2003, 2005, 2007-ongoing;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
573;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.103;Q4;8;7;7;0;0;7;0;0;India;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007;Pharmacology (Q4)
574;13637;Manufacturing Chemist;journal;02624230;0.103;Q4;6;79;153;165;0;138;0;2.09;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science (Q4)
575;19700174891;Perspectives in Medicinal Chemistry;journal;1177391X;0.103;Q4;13;3;7;212;0;7;0;70.67;New Zealand;Libertas Academica;2008-2011, 2014-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
576;21077;Pharmaca;journal;00316857;0.103;Q4;4;15;45;246;2;38;0.07;16.4;Croatia;Association of Croatian Health Organizations;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
577;19430;Adverse Drug Reaction Bulletin;journal;00446394;0.102;Q4;7;4;16;173;2;16;0.08;43.25;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
578;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0.102;Q4;7;96;7;1585;0;7;0;16.51;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
579;144718;Enhancer - Biotherapy of Cancer;journal;15720004;0.102;Q4;0;0;15;0;0;11;0;0;United States;Duke University Press;2005-2006;"Cancer Research (Q4); Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Oncology (Q4)"
580;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.102;Q4;6;13;12;458;0;12;0;35.23;Turkey;Hacettepe Universitesi;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
581;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.102;Q4;5;11;9;212;4;9;0.44;19.27;Nigeria;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009;Pharmacology (Q4)
582;19700182629;Methods in Pharmacology and Toxicology;book series;15572153;0.102;Q4;6;0;22;0;1;21;0.05;0;United States;Humana Press, Inc.;2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
583;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.102;Q4;2;0;17;0;1;11;0.09;0;Germany;Wissenschaftliche Verlagsgesellschaft;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
584;145000;Signal;journal;14719967;0.102;Q4;1;0;12;0;0;10;0;0;United Kingdom;Adis International Ltd.;2005-2007;"Drug Discovery (Q4); Oncology (Q4); Pharmacology (medical) (Q4)"
585;19700175137;Trends in Medical Research;journal;18193587;0.102;Q4;8;9;11;193;1;11;0.09;21.44;United States;Academic Journals Inc.;2008-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
586;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0.101;Q4;9;7;27;52;0;19;0;7.43;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
587;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.101;Q4;2;11;18;0;0;17;0;0;Japan;Research Laboratory of Shionogi and Co.;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
588;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.101;Q4;4;19;44;430;1;41;0.02;22.63;Venezuela;Tribuna Medica Venezolana;2007-2013, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
589;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.101;Q4;7;23;26;653;1;25;0.04;28.39;Egypt;Faculty of Pharmacy, Assiut University;2008-2013;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
590;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.101;Q4;6;0;25;0;0;20;0;0;Spain;Alpe Editores;1996-2007;Pharmacology (Q4)
591;4700152278;Drugs in Context;journal;17404398, 17451981;0.101;Q4;12;0;75;0;1;59;0;0;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4)"
592;21238;Drug Topics;journal;00126616;0.101;Q4;7;133;1114;28;8;865;0.01;0.21;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
593;19200156912;EJHP Practice;journal;20303769, 17819989;0.101;Q4;5;123;25;766;1;22;0.05;6.23;Belgium;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
594;21823;Farmatsija;journal;04280296;0.101;Q4;5;8;39;156;1;39;0.05;19.5;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
595;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0.101;Q4;7;145;176;908;5;172;0.03;6.26;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
596;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.101;Q4;8;0;22;0;2;20;0.09;0;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
597;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.101;Q4;5;235;793;2611;17;793;0.03;11.11;China;Jilin University;2005-ongoing;Pharmacology (Q4)
598;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.101;Q4;7;0;26;0;0;26;0;0;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
599;20572;PZ Prisma;journal;09455566;0.101;Q4;5;33;78;624;3;68;0.03;18.91;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
600;19408;Actualites Pharmaceutiques;journal;05153700;0.1;Q4;5;133;509;161;1;456;0;1.21;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
601;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;2;39;115;405;0;99;0;10.38;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
602;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.1;Q4;2;29;185;72;0;165;0;2.48;Germany;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
603;5200152843;Farmaceutico Hospitales;journal;02144697;0.1;Q4;3;14;68;181;0;53;0;12.93;Spain;Ediciones Mayo;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
604;15680;Giornale di Neuropsicofarmacologia;journal;03919048;0.1;Q4;1;0;45;0;0;38;0;0;Italy;C I C Edizioni International srl;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
605;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0.1;Q4;18;57;86;854;3;85;0.04;14.98;India;Aall India Institute of Medical Sciences;2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Law (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
606;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;98;661;2;0;232;0;0.02;Spain;Reed Business Information Ltd;2006-2011;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
607;25197;Revista de Toxicologia;journal;16970748, 02127113;0.1;Q4;9;11;47;376;0;46;0;34.18;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
608;5800207507;Side Effects of Drugs Annual;book series;03786080;0.1;Q4;5;52;103;3693;2;53;0.04;71.02;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
609;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0.1;Q4;12;74;79;1015;0;78;0;13.72;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
610;19700181314;2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009;conference and proceedings;00002009;;-;4;71;0;895;0;0;0;12.61;United States;;2009;"Molecular Medicine; Pharmacology"
611;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;;-;22;4;0;180;0;0;0;45;Egypt;Hindawi Publishing Corporation;2009-ongoing;"Molecular Medicine; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
612;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;;-;25;102;0;2775;0;0;0;27.21;Nigeria;Academic Journals;2009-2011;"Pharmaceutical Science; Pharmacology"
613;19700182251;Air and Waste Management Association - Harmonizing Greenhouse Gas Assessment and Reporting Processes 2009;conference and proceedings;00002009;;-;0;44;0;259;0;0;0;5.89;United States;;2009;"Ecology; Pollution; Toxicology; Waste Management and Disposal"
614;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;;-;10;45;0;976;0;0;0;21.69;Iran;Shahid Beheshti University of Medical Sciences;2012-ongoing;"Cardiology and Cardiovascular Medicine; Critical Care and Intensive Care Medicine; Infectious Diseases; Public Health, Environmental and Occupational Health; Toxicology"
615;19700171709;Arhiv za Farmaciju;journal;00041963, 22178767;;-;3;36;0;868;0;0;0;24.11;Serbia;Farmaceutsko Drustvo Srbije;1954-1955, 2009-ongoing;"Pharmaceutical Science; Pharmacology"
616;19700174904;Asian Journal of Pharmaceutical and Clinical Research;journal;09742441, 24553891;;-;26;59;0;1360;0;0;0;23.05;India;Asian Journal of Pharmaceutical and Clinical Research;2009-ongoing;"Pharmaceutical Science; Pharmacology; Pharmacology (medical)"
617;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876;;-;27;40;0;1219;0;0;0;30.48;China;Shenyang Pharmaceutical University;2009-ongoing;"Pharmaceutical Science; Pharmacology"
618;19700174931;Asian Journal of Pharmaceutics;journal;1998409X, 09738398;;-;16;61;0;1291;0;0;0;21.16;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
619;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;;-;2;36;0;414;0;0;0;11.5;Azerbaijan;Azarbaucan Tibb Universiteti;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
620;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;;-;19;34;0;629;0;0;0;18.5;Bangladesh;Bangladesh Pharmacological Society;2009-ongoing;Pharmacology
621;19700188217;Bioanalysis;journal;17576180, 17576199;;-;51;127;0;6519;0;0;0;51.33;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Analytical Chemistry; Clinical Biochemistry; Medical Laboratory Technology; Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
622;19700174924;Biomedical and Pharmacology Journal;journal;09746242, 24562610;;-;12;88;0;1498;0;0;0;17.02;India;Oriental Scientific Pub. Co.;2009-ongoing;Pharmacology
623;19700174961;BioProcess International;trade journal;15426319;;-;20;150;0;803;0;0;0;5.35;United States;BioProcess International;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Drug Discovery"
624;19700200880;Botulinum Journal;journal;17547326;;-;5;8;0;195;0;0;0;24.38;Switzerland;Inderscience Publishers;2009-2013, 2016-ongoing;"Biochemistry; Cellular and Molecular Neuroscience; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
625;19200156925;Cancer Therapy;journal;15439143, 15439135;;-;8;47;0;2126;0;0;0;45.23;United States;Gene Therapy Press;2009-2014;"Cancer Research; Oncology; Pharmacology"
626;19700173109;Contract Pharma;trade journal;15443469;;-;3;103;0;80;0;0;0;0.78;United States;Contract Pharma;2009-ongoing;"Industrial Relations; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
627;19700175244;Current Radiopharmaceuticals;journal;18744710;;-;21;32;0;1299;0;0;0;40.59;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmacology; Radiology, Nuclear Medicine and Imaging"
628;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;;-;14;18;0;357;0;0;0;19.83;Netherlands;Elsevier BV;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Pharmacy"
629;17300154738;Current Trends in Biotechnology and Pharmacy;journal;09738916;;-;10;37;0;1163;0;0;0;31.43;India;Association of Biotechnology and Pharmacy;2009-ongoing;"Biotechnology; Drug Discovery; Pharmaceutical Science"
630;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;;-;35;22;0;1209;0;0;0;54.95;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Internal Medicine; Pharmacology"
631;17600155051;Drug Delivery Technology;trade journal;15372898;;-;9;64;0;578;0;0;0;9.03;United States;Drug Delivery Technology, LLC;2009-ongoing;Pharmaceutical Science
632;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;;-;18;10;0;367;0;0;0;36.7;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Health Policy; Pharmacology"
633;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;;-;44;78;0;2547;0;0;0;32.65;United Kingdom;John Wiley & Sons Ltd.;2009-ongoing;"Analytical Chemistry; Environmental Chemistry; Pharmaceutical Science; Spectroscopy"
634;15600154705;EnvironmentAsia;journal;19061714;;-;14;16;0;292;0;0;0;18.25;Thailand;Thai Society of Higher Education Institutes on Environment;2009-ongoing;"Environmental Science (miscellaneous); Toxicology"
635;19700182785;Ethiopian Pharmaceutical Journal;journal;10295933;;-;3;15;0;361;0;0;0;24.07;Ethiopia;Ethiopian Pharmaceutical Association;2009;"Pharmaceutical Science; Pharmacology"
636;19700174996;European Life Science Journal;trade journal;20001444;;-;1;86;0;0;0;0;0;0;Thailand;The Psychiatric Association of Thailand;2009-2011;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
637;21100804474;European Pharmaceutical Journal;journal;24536725;;-;5;21;0;351;0;0;0;16.71;Germany;de Gruyter;2016-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
638;19700174925;European Pharmaceutical Review;trade journal;13608606;;-;7;29;0;402;0;0;0;13.86;United Kingdom;Russell Publishing Ltd;2009-ongoing;"Biochemistry; Biophysics; Biotechnology; Molecular Medicine; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
639;19700170617;EXCLI Journal;journal;16112156;;-;24;28;0;924;0;0;0;33;Germany;University of Mainz;2009-ongoing;"Animal Science and Zoology; Drug Discovery; Molecular Medicine; Pharmacology"
640;19500157008;Fooyin Journal of Health Sciences;journal;18778607;;-;5;14;0;387;0;0;0;27.64;Netherlands;Elsevier BV;2009-2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Biomedical Engineering; Drug Discovery; Medicine (miscellaneous)"
641;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;;-;54;121;0;8610;0;0;0;71.16;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Drug Discovery; Molecular Medicine; Pharmacology"
642;19400158813;HIV Therapy;journal;17584329, 17584310;;-;12;60;0;3725;0;0;0;62.08;United Kingdom;Future Medicine Ltd.;2009-2010;"Dermatology; Drug Discovery; Infectious Diseases; Pharmacology; Pharmacology (medical); Virology"
643;19700175015;Infection and Drug Resistance;journal;11786973;;-;27;6;0;435;0;0;0;72.5;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Infectious Diseases; Pharmacology; Pharmacology (medical)"
644;15500154707;International Journal of Biological Chemistry;journal;1819155X;;-;12;17;0;421;0;0;0;24.76;Pakistan;ANSInet;2009-2016 (cancelled);"Biochemistry; Pharmacology"
645;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;19430868, 1943085X;;-;11;11;0;580;0;0;0;52.73;United States;Taylor and Francis;2009-2012;"Biomedical Engineering; Nanoscience and Nanotechnology; Pharmaceutical Science"
646;19700174900;International Journal of Green Pharmacy;journal;19984103, 09738258;;-;18;68;0;1574;0;0;0;23.15;India;Medknow Publications;2009-ongoing;"Pharmaceutical Science; Pharmacology"
647;19700174926;International Journal of Health Research;journal;15969819, 15969886;;-;7;33;0;762;0;0;0;23.09;Nigeria;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous); Pharmacology"
648;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences;journal;09751491;;-;37;77;0;1625;0;0;0;21.1;India;International Journal of Pharmacy and Pharmaceutical Sciences;2009-2016 (cancelled);"Pharmaceutical Science; Pharmacology"
649;19700175060;International Journal of PharmTech Research;journal;24559563, 09744304;;-;40;275;0;5505;0;0;0;20.02;India;Sphinx Knowledge House;2009-2016 (cancelled);"Pharmaceutical Science; Pharmacology"
650;19700175125;Internet Journal of Pharmacology;journal;15312976;;-;7;41;0;1284;0;0;0;31.32;United States;Internet Scientific Publications;2009-2011;Pharmacology
651;19700175049;Internet Journal of Toxicology;journal;15593916;;-;5;17;0;397;0;0;0;23.35;United States;Internet Scientific Publications;2009-2011, 2013, 2015;Toxicology
652;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;;-;8;16;0;348;0;0;0;21.75;Jordan;University of Jordan;2009-ongoing;Pharmaceutical Science
653;19600156803;Journal of Medicinal Plant Research;journal;19960875;;-;47;157;0;4185;0;0;0;26.66;Nigeria;Academic Journals;2009-2011;"Complementary and Alternative Medicine; Drug Discovery; Pharmaceutical Science; Pharmacology; Plant Science"
654;19700174933;Journal of Pharmaceutical Sciences and Research;journal;09751459;;-;20;66;0;1293;0;0;0;19.59;India;PharmaInfo Publications;2009-ongoing;Pharmaceutical Science
655;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;;-;4;38;0;683;0;0;0;17.97;Czech Republic;SOLEN s.r.o.;2009-ongoing;"Pharmaceutical Science; Pharmacology; Pharmacy"
656;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;17;121;260;3232;75;260;0.29;26.71;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-ongoing;"Drug Discovery; Pharmaceutical Science"
657;19700169211;Life Science Clusters;trade journal;17528119;;-;0;60;0;23;0;0;0;0.38;United Kingdom;Avakado Limited;2009-2010;"Biotechnology; Industrial Relations; Management of Technology and Innovation; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
658;17700156705;Modern Trends in Pharmacopsychiatry;book series;16622685;;-;10;10;0;612;0;0;0;61.2;Switzerland;Karger;2009-2010, 2013-ongoing;"Medicine (miscellaneous); Pharmacology; Psychiatry and Mental Health"
659;19700174906;Molecular and Cellular Pharmacology;journal;19381247;;-;21;32;0;1713;0;0;0;53.53;United States;Lumitext Publishing;2009-ongoing;"Molecular Biology; Pharmaceutical Science"
660;17700156303;Neuromethods;book series;19406045, 08932336;;-;17;64;0;4981;0;0;0;77.83;United States;Humana Press, Inc.;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Neuroscience (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Psychiatry and Mental Health"
661;19700175602;Next Generation Pharmaceutical;trade journal;-;;-;1;109;0;4;0;0;0;0.04;United Kingdom;GDS International;2009-2011;"Drug Discovery; Marketing; Organizational Behavior and Human Resource Management; Pharmaceutical Science; Pharmacology; Strategy and Management"
662;19700174997;ONdrugDelivery;trade journal;2049145X;;-;5;4;0;0;0;0;0;0;United Kingdom;Frederick Furness Publishing;2009-ongoing;Pharmaceutical Science
663;19700175785;Open Access Journal of Clinical Trials;journal;11791519;;-;9;4;0;332;0;0;0;83;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
664;19700175071;Open Bioactive Compounds Journal;journal;18748473;;-;5;3;0;156;0;0;0;52;United Arab Emirates;Bentham Science Publishers;2009-2010, 2013;"Biochemistry; Drug Discovery; Molecular Biology; Molecular Medicine; Pharmaceutical Science; Pharmacology"
665;19700175105;Open Drug Delivery Journal;journal;18741266;;-;5;3;0;98;0;0;0;32.67;United Arab Emirates;Bentham Science Publishers;2009-2010, 2014;Pharmaceutical Science
666;19700175004;Open Medicinal Chemistry Journal;journal;18741045;;-;15;1;0;23;0;0;0;23;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Drug Discovery; Molecular Medicine; Pharmaceutical Science; Pharmacology"
667;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;;-;5;12;0;838;0;0;0;69.83;United Arab Emirates;Bentham Science Publishers;2009-2012;"Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
668;19700175061;Open Pharmacology Journal;journal;18741436;;-;6;5;0;231;0;0;0;46.2;United Arab Emirates;Bentham Science Publishers;2009-2013;"Drug Discovery; Molecular Medicine; Pharmaceutical Science; Pharmacology"
669;19700175039;Open Toxicology Journal;journal;18743404;;-;5;7;0;264;0;0;0;37.71;United Arab Emirates;Bentham Science Publishers;2009-2013;Toxicology
670;19700175040;Open Vaccine Journal;journal;18750354;;-;9;13;0;772;0;0;0;59.38;United Arab Emirates;Bentham Science Publishers;2009-2013;"Drug Discovery; Immunology; Pharmaceutical Science"
671;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;;-;3;71;0;238;0;0;0;3.35;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2009-ongoing;"Pharmaceutical Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
672;19700175034;Pharmaceutical Processing;trade journal;10499156;;-;2;58;0;73;0;0;0;1.26;United States;Advantage Business Media;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
673;19700175002;Pharmaceutical Reviews;journal;19185561;;-;4;32;0;1341;0;0;0;41.91;India;PharmaInfo Publications;2009-2011;"Analytical Chemistry; Drug Discovery; Pharmaceutical Science; Pharmacology"
674;17700156714;Pharmaceuticals;journal;14248247;;-;44;14;0;464;0;0;0;33.14;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2009-ongoing;"Molecular Medicine; Pharmaceutical Science"
675;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;;-;12;42;0;1115;0;0;0;26.55;Iran;Tabriz University of Medical Sciences;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
676;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;;-;22;9;0;508;0;0;0;56.44;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Molecular Medicine; Pharmacology"
677;19700175096;Pharmacognosy Journal;journal;09753575;;-;14;40;0;647;0;0;0;16.18;India;Pharmacognosy Network Worldwide;2009-ongoing;"Drug Discovery; Pharmacology"
678;19700175143;Pharmacognosy Reviews;journal;09737847, 09762787;;-;36;41;0;3074;0;0;0;74.98;India;Medknow Publications;2009-ongoing;"Complementary and Alternative Medicine; Drug Discovery; Pharmacology; Plant Science"
679;20543;Pharmacometrics;journal;03008533;;-;6;16;0;163;0;0;0;10.19;Japan;Japanese Society or Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
680;19700181241;Physiology and Pharmacology;journal;24765236, 24765244;;-;9;46;0;1432;0;0;0;31.13;Iran;Neuroscience Research Center;2009-ongoing;"Pharmacology; Physiology"
681;19500156813;Procedia in Vaccinology;journal;1877282X;;-;10;32;0;591;0;0;0;18.47;Netherlands;Elsevier BV;2009-2012;"Drug Discovery; Immunology; Infectious Diseases; Pharmaceutical Science"
682;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;;-;2;11;0;342;0;0;0;31.09;Russian Federation;SRL Archive;2009-2012;"Pharmacology; Psychiatry and Mental Health"
683;19700177006;Psychopharm Review;trade journal;19369255;;-;4;12;0;551;0;0;0;45.92;United States;Lippincott Williams & Wilkins Ltd.;2009-2014;"Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
684;17500155003;Records of Natural Products;journal;13076167;;-;24;25;0;499;0;0;0;19.96;Turkey;ACG Publications;2009-ongoing;"Drug Discovery; Organic Chemistry; Pharmacology; Plant Science"
685;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;;-;20;12;0;262;0;0;0;21.83;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
686;17700155411;Research Journal of Environmental Toxicology;journal;18193420;;-;12;16;0;514;0;0;0;32.13;United States;Academic Journals Inc.;2009-2016 (cancelled);"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
687;19700174987;Research Journal of Toxins;journal;18193560;;-;2;2;0;86;0;0;0;43;United States;Academic Journals Inc.;2009, 2014-2016 (cancelled);"Agronomy and Crop Science; Food Science; Toxicology"
688;19700174940;SA Pharmaceutical Journal;journal;10151362;;-;6;137;0;804;0;0;0;5.87;South Africa;Medpharm Publications Ltd.;2009-ongoing;Pharmaceutical Science
689;16800154712;Sp2;trade journal;1476184X;;-;1;64;0;50;0;0;0;0.78;United Kingdom;Manor Creative;2009-2014;"Drug Discovery; Molecular Medicine"
690;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685;;-;11;12;0;434;0;0;0;36.17;Thailand;Chulalongkorn University;2009-ongoing;"Pharmaceutical Science; Pharmacology"
691;19700175099;Topics in Medicinal Chemistry;book series;18622461;;-;8;10;0;913;0;0;0;91.3;Germany;Springer Verlag;2009-ongoing;"Drug Discovery; Molecular Medicine"
692;21100226424;Toxicology and Environmental Health Sciences;journal;20059752;;-;12;30;0;833;0;0;0;27.77;South Korea;Korean Society of Environmental Risk Assessment and Health Science;2009-ongoing;"Health, Toxicology and Mutagenesis; Toxicology"
693;19700188352;Toxins;journal;20726651;;-;56;16;0;0;0;0;0;0;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;"Health, Toxicology and Mutagenesis; Toxicology"
694;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996;;-;29;66;0;1423;0;0;0;21.56;Nigeria;University of Benin;2009-ongoing;"Pharmaceutical Science; Pharmacology (medical)"
695;19700170837;Vitae;journal;01214004;;-;11;40;0;1255;0;0;0;31.38;Colombia;Universidad de Antioquia;2009-ongoing;"Applied Microbiology and Biotechnology; Bioengineering; Biotechnology; Food Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
696;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;;-;30;49;0;2215;0;0;0;45.2;Netherlands;Wageningen Academic Publishers;2009-ongoing;"Food Science; Public Health, Environmental and Occupational Health; Toxicology"
